UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 34

Sortiert nach

Diabetes and dyslipidaemia are associated with oxidative stress independently of inflammation in long-term antiretroviral-treated HIV-infected patients

Diabetes & metabolism, 2019-12, Vol.45 (6), p.573-581

2019

Link zum Volltext

Verfügbarkeit prüfen

The Use of Model-Based Tumor-Size Metrics to Predict Survival

Clinical pharmacology and therapeutics, 2014-08, Vol.96 (2), p.133-135

2014

Link zum Volltext

Verfügbarkeit prüfen

Effect of Adherence as Measured by MEMS, Ritonavir Boosting, and CYP3A5 Genotype on Atazanavir Pharmacokinetics in Treatment-Naive HIV-Infected Patients

Clinical pharmacology and therapeutics, 2012-11, Vol.92 (5), p.575-583

2012

Link zum Volltext

Verfügbarkeit prüfen

The ISoP Standards and Best Practices Committee

Clinical pharmacology and therapeutics, 2014-06, Vol.95 (6), p.581-582

2014

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetic Similarity of Biologics: Analysis Using Nonlinear Mixed-Effects Modeling

Clinical pharmacology and therapeutics, 2012-02, Vol.91 (2), p.234-242

2012

Link zum Volltext

Verfügbarkeit prüfen

Association between Nasal Carriage of Staphylococcus Aureus and Infection in Liver Transplant Recipients

Clinical infectious diseases, 2000-11, Vol.31 (5), p.1295-1299

2000

Link zum Volltext

Verfügbarkeit prüfen

Dose Rationale for Favipiravir Use in Patients Infected With SARS-CoV-2: Clin Pharmacol Ther

Clinical pharmacology and therapeutics, 2020, Vol.108 (2)

2020

Link zum Volltext

Verfügbarkeit prüfen

A Pharmacokinetic-Viral Kinetic Model Describes the Effect of Alisporivir as Monotherapy or in Combination With Peg-IFN on Hepatitis C Virologic Response

Clinical pharmacology and therapeutics, 2014-11, Vol.96 (5), p.599-608

2014

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetic and Pharmacodynamic Variability of Fluindione in Octogenarians

Clinical pharmacology and therapeutics, 2012-05, Vol.91 (5), p.777-786

2012

Link zum Volltext

Verfügbarkeit prüfen

Maintenance therapy with cotrimoxazole for toxoplasmic encephalitis in the era of highly active antiretroviral therapy

AIDS (London), 2004-06, Vol.18 (9), p.1342-1344

2004

Link zum Volltext

Verfügbarkeit prüfen

Population pharmacokinetic-pharmacodynamic analysis of fluindione in patients

Clinical pharmacology and therapeutics, 1998-01, Vol.63 (1), p.64-78

1998

Link zum Volltext

Verfügbarkeit prüfen

Cerebral uptake of mefloquine enantiomers with and without the P‐gp inhibitor elacridar (GF1210918) in mice

British journal of pharmacology, 2004-04, Vol.141 (7), p.1214-1222

2004

Link zum Volltext

Verfügbarkeit prüfen

B-Type Natriuretic Peptide and Echocardiographic Determination of Ejection Fraction in the Diagnosis of Congestive Heart Failure in Patients With Acute Dyspnea

Chest, 2005-07, Vol.128 (1), p.21-29

2005

Link zum Volltext

Verfügbarkeit prüfen

Absence of association between MDR1 genetic polymorphisms, indinavir pharmacokinetics and response to highly active antiretroviral therapy

AIDS (London), 2005-12, Vol.19 (18), p.2127-2131

2005

Link zum Volltext

Verfügbarkeit prüfen

Cetuximab as first-line monotherapy in patients with skin unresectable squamous cell carcinoma: Final results of a phase II multicenter study

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.8510-8510

2010

Link zum Volltext

Verfügbarkeit prüfen

PII-44Population pharmacokinetic models for ritonavir boosted atazanavir and tenofovir in highly pretreated HIV infected patients

Clinical pharmacology and therapeutics, 2006-02, Vol.79 (2), p.P47-P47

2006

Link zum Volltext

Verfügbarkeit prüfen

Population kinetics and conditional assessment of the optimal dosage regimen using the P-PHARM software package

Anticancer research, 1994-11, Vol.14 (6A), p.2321

1994

Link zum Volltext

Verfügbarkeit prüfen

Effect of efflux inhibition on brain uptake of itraconazole in mice infected with Cryptococcus neoformans

Drug metabolism and disposition, 2003-03, Vol.31 (3), p.319

2003

Link zum Volltext

Verfügbarkeit prüfen

Sparse-Sampling Optimal Designs in Pharmacokinetics and Toxicokinetics

Therapeutic innovation & regulatory science, 1995, Vol.29 (3), p.997-1019

1995

Link zum Volltext

Verfügbarkeit prüfen

Population pharmacodynamic analysis of octreotide in acromegalic patients

Clinical pharmacology and therapeutics, 2003-01, Vol.73 (1), p.95-106

2003

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetic and pharmacodynamic modeling of mizolastine in healthy volunteers with an indirect response model

Clinical pharmacology and therapeutics, 2000-12, Vol.68 (6), p.647-657

2000

Link zum Volltext

Verfügbarkeit prüfen

Maintenance therapy with cotrimoxazole for toxoplasmic encephalitis in the era of highly active antiretroviral therapy

AIDS (London), 2004-06, Vol.18 (9), p.1342-1344

2004

Link zum Volltext

Verfügbarkeit prüfen

Adherence intervention for HIV-infected patients receiving antiretrovirai treatment implementation and initial assessment

La Presse médicale (1983), 2006-09, Vol.35 (9), p.1241-1248

2006

Link zum Volltext

Verfügbarkeit prüfen

Cetuximab as first-line monotherapy in patients with unresectable squamous cell carcinoma of the skin: Preliminary results of a phase II multicenter study

Journal of clinical oncology, 2008-05, Vol.26 (15_suppl), p.9042-9042

2008

Link zum Volltext

Verfügbarkeit prüfen

Plasma Concentrations of Zidovudine

The New England journal of medicine, 1992-06, Vol.326 (23), p.1571-1571

1992

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 34

Suche als RSS-Feed

Aktive Filter

PublikationsformBerichte

KollektionSingle Journals

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(30)
Mit Volltextzugriff
(29)

Publikationsform

Artikel
(33)
Reviews
(1)

Sprache

Englisch
(32)
Französisch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Diabetes and dyslipidaemia are associated with oxidative stress independently of inflammation in long-term antiretroviral-treated HIV-infected patients

The Use of Model-Based Tumor-Size Metrics to Predict Survival

Effect of Adherence as Measured by MEMS, Ritonavir Boosting, and CYP3A5 Genotype on Atazanavir Pharmacokinetics in Treatment-Naive HIV-Infected Patients

The ISoP Standards and Best Practices Committee

Pharmacokinetic Similarity of Biologics: Analysis Using Nonlinear Mixed-Effects Modeling

Association between Nasal Carriage of Staphylococcus Aureus and Infection in Liver Transplant Recipients

Dose Rationale for Favipiravir Use in Patients Infected With SARS-CoV-2: Clin Pharmacol Ther

A Pharmacokinetic-Viral Kinetic Model Describes the Effect of Alisporivir as Monotherapy or in Combination With Peg-IFN on Hepatitis C Virologic Response

Pharmacokinetic and Pharmacodynamic Variability of Fluindione in Octogenarians

Maintenance therapy with cotrimoxazole for toxoplasmic encephalitis in the era of highly active antiretroviral therapy

Population pharmacokinetic-pharmacodynamic analysis of fluindione in patients

Cerebral uptake of mefloquine enantiomers with and without the P‐gp inhibitor elacridar (GF1210918) in mice

B-Type Natriuretic Peptide and Echocardiographic Determination of Ejection Fraction in the Diagnosis of Congestive Heart Failure in Patients With Acute Dyspnea

Absence of association between MDR1 genetic polymorphisms, indinavir pharmacokinetics and response to highly active antiretroviral therapy

Cetuximab as first-line monotherapy in patients with skin unresectable squamous cell carcinoma: Final results of a phase II multicenter study

PII-44Population pharmacokinetic models for ritonavir boosted atazanavir and tenofovir in highly pretreated HIV infected patients

Population kinetics and conditional assessment of the optimal dosage regimen using the P-PHARM software package

Effect of efflux inhibition on brain uptake of itraconazole in mice infected with Cryptococcus neoformans

Sparse-Sampling Optimal Designs in Pharmacokinetics and Toxicokinetics

Population pharmacodynamic analysis of octreotide in acromegalic patients

Pharmacokinetic and pharmacodynamic modeling of mizolastine in healthy volunteers with an indirect response model

Maintenance therapy with cotrimoxazole for toxoplasmic encephalitis in the era of highly active antiretroviral therapy

Adherence intervention for HIV-infected patients receiving antiretrovirai treatment implementation and initial assessment

Cetuximab as first-line monotherapy in patients with unresectable squamous cell carcinoma of the skin: Preliminary results of a phase II multicenter study

Plasma Concentrations of Zidovudine

Aktive Filter

Suchergebnisse filtern